肥胖与慢性肢体威胁性缺血下肢血运重建后无截肢生存的关系:回顾性队列研究
结果显示全组1年AFS无显著差异(合并P=0.335),但肥胖组较正常BMI组调整后截肢/死亡复合风险显著降低(aHR 0.39,95%CI 0.16-0.92,P=0.032),超重、病态肥胖及体重过低组均无显著差异。
要点
- CLTI血运重建患者中,肥胖与1年无截肢生存改善相关(aHR 0.39,95%CI 0.16-0.92,P=0.032)。
- 全组1年无截肢生存无显著差异(合并P=0.335),超重、病态肥胖及体重过低组均无显著差异。
- 结果支持CLTI中存在肥胖悖论,提示体重管理指南可能需要更个体化。
核心结论
- 在CLTI背景下,肥胖可能与1年无截肢生存改善相关,支持肥胖悖论的存在。
研究设计与样本
- BMI按世界卫生组织标准分层,主要终点为1年无截肢生存(大截肢或死亡的复合终点)。
- 采用Kaplan-Meier生存分析和调整Cox比例风险模型,以正常体重组为参照进行比较。
主要发现
- 全组1年无截肢生存无显著差异(合并P=0.335)。
- 肥胖组(n=43)较正常BMI组(n=66)调整后截肢/死亡复合风险显著降低(aHR 0.39,95%CI 0.16-0.92,P=0.032)。
- 超重组调整后风险无显著差异(aHR 0.89,95%CI 0.47-1.70,P=0.741)。
- 病态肥胖组调整后风险无显著差异(aHR 1.15,95%CI 0.41-3.20,P=0.797)。
- 体重过低组调整后风险无显著差异(aHR 1.86,95%CI 0.56-6.20,P=0.314)。
临床怎么用
- 评估CLTI患者血运重建预后时,可将BMI纳入考量,但不应据此改变体重管理的一般原则。
- 肥胖患者可能不应因体重因素而延迟或拒绝下肢血运重建。
- 需更多研究验证肥胖悖论,以指导CLTI患者个体化体重管理。
局限性
- 肥胖组样本量较小(n=43),亚组分析效能有限。
- 仅依据BMI分类,未考虑体成分、肥胖病程及代谢健康状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The obesity paradox is a well-documented phenomenon in cardiovascular disease, however it remains poorly understood. We aimed to investigate the relationship between body mass (as measured by body mass index [BMI]) and 1-year amputation-free survival (AFS) for patients undergoing lower limb revascularisation for chronic limb-threatening ischaemia (CLTI). METHODS: A retrospective analysis was undertaken of all consecutive patients undergoing lower limb revascularisation for CLTI at the Leicester Vascular Institute between February 2018-19. Baseline demographics and outcomes were collected using electronic records. BMI was stratified using the World Health Organization criteria. One-year AFS (composite of major amputation/death) was the primary outcome. Kaplan-Meier survival analysis and adjusted Cox's proportional hazard models were used to compare groups to patients of normal mass. RESULTS: One-hundred and ninety patients were included. Overall, no difference was identified in 1-year AFS across all groups (pooled P = 0.335). Compared to patients with normal BMI (n = 66), obese patients (n = 43) had a significantly lower adjusted combined risk of amputation/death (aHR 0.39, 95% CI 0.16-0.92, P = 0.032), however no significant differences were observed for overweight (aHR 0.89, 95% CI 0.47-1.70, P = 0.741), morbidly obese (aHR 1.15, 95% CI 0.41-3.20, P = 0.797) and underweight individuals (aHR 1.86, 95% CI 0.56-6.20, P = 0.314). CONCLUSIONS: In the context of CLTI, obesity is potentially associated with favourable amputation-free survival at 1 year, compared to normal body mass. The results of this study support the notion of an obesity paradox existing within CLTI and question whether current guidance on weight management requires a more patient-specific approach.
引用
- Sabbagh C, Nickinson A, Cullen S, et al. The Relationship Between Obesity and Amputation-free Survival in Patients Undergoing Lower-limb Revascularisation for Chronic Limb-threatening Ischaemia: A Retrospective Cohort Study. Ann Vasc Surg. 2021. PMID: 34474129. doi:10.1016/j.avsg.2021.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。